drugset / Trial / NCT05729074
A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients
RandomizedSequentialTriple-blindTreatment
Summary
This study aims to evaluate the safety, tolerability and pharmacokinetic properties of IN-A002 Ointment in healthy adult male volunteers and mild to moderate atopic dermatitis patients
Timeline
- Start
- 2023-02-13
- Primary completion
- 2023-02-25
- Completion
- 2024-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IN-A002 | Unknown | 0.3 % | Topical |
| Subject | IN-A002 | Unknown | 0.5 % | Topical |
| Subject | IN-A002 | Unknown | 1 % | Topical |
| Subject | IN-A002 | Unknown | 3 % | Topical |
| Subject | IN-A002 | Unknown | 5 % | Topical |
| Comparator | Pimecrolimus | Small molecule | 1 % | Topical |